Version française
Institutes/ Institute of biomedical imaging (I²BM)/ Departments/ Frédéric Joliot Hospital Service (SHFJ)/ Publications

Publications  - 2006

2012 - 2011 - 2010 - 2009 - 2008 - 2006 - 2005 - 2004 - 2003 - 2002
  1. Bachoud-Levi AC, Gaura V, Brugieres P, Lefaucheur JP, Boisse MF, Maison P, Baudic S, Ribeiro MJ, Bourdet C, Remy P, Cesaro P, Hantraye P, Peschanski M. (2006). Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study Lancet Neurol. 5, 303-309.
  2. Baudic S, Dalla Barba G, Thibaudet MC, Smagghe A, Remy P, Traykov L. (2006). Executive function deficits in early Alzheimer's disease and their relations with episodic memory Arch Clin Neuropsych. 21, 15-21.
  3. Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P, Deglon N, Brouillet E. (2006). Involvement of Mitochondrial Complex II Defects in Neuronal Death Produced by N-Terminus Fragment of Mutated Huntingtin. Mol Biol Cell. 17, 1652-1663.
  4. Le Bihan D, Urayama S, Aso T, Hanakawa T, Fukuyama H. (2006). Direct and fast detection of neuronal activation in the human brain with diffusion MRI. Proc Natl Acad Sci U S A. 103, 8263-8268.
  5. Le Bihan D, Poupon C, Amadon A, Lethimonnier F. (2006). Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging. 24, 478-488.
  6. Boddaert N, Mochel F, Meresse I, Seidenwurm D, Cachia A, Brunelle F, Lyonnet S, Zilbovicius M. (2006). Parieto-occipital grey matter abnormalities in children with Williams syndrome. NeuroImage. 30, 721-725.
  7. Borrell-Pages M, Canals JM, Cordelieres FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, Cheetham ME, Neri C, Alberch J, Brouillet E, Saudou F, Humbert S. (2006). Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest. in print
  8.  Chalon S, Hall H, Saba W, Garreau L, Dolle F, Halldin C, Emond P, Bottlaender M, Deloye JB, Helfenbein J, Madelmont JC, Bodard S, Mincheva Z, Besnard JC, Guilloteau D (2006) Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter. J Pharmacol Exp Ther 317:147-152
  9. Chauveau F, Pestourie C, Tavitian B. (2006). [Aptamers: selection and scope of applications] Pathol Biol (Paris). 54, 251-258.
  10. Coyle TR, Kochunov P, Patel RD, Nery FG, Lancaster JL, Mangin JF, Riviere D, Pillow DR, Davis GJ, Nicoletti MA, Serap Monkul E, Fox PT, Soares JC. (2006). Cortical sulci and bipolar disorder. Neuroreport. 17, 1739-1742.
  11. Dehaene-Lambertz G, Dehaene S, Anton JL, Campagne A, Ciuciu P, Dehaene GP, Denghien I, Jobert A, LeBihan D, Sigman M, Pallier C, Poline JB. (2006). Functional segregation of cortical language areas by sentence repetition. Hum Brain Mapp. 27, 360-371.
  12. Dehaene-Lambertz G, Hertz-Pannier L, Dubois J. (2006). Nature and nurture in language acquisition: anatomical and functional brain-imaging studies in infants Trends Neurosci. 29, 367-373.
  13. Dehaene-Lambertz G, Hertz-Pannier L, Dubois J, Meriaux S, Roche A, Sigman M, Dehaene S. (2006). Functional organization of perisylvian activation during presentation of sentences in preverbal infants. Proc Natl Acad Sci U S A. 103, 14240-14245.
  14. Dehaene S, Izard V, Pica P, Spelke E. (2006). Core knowledge of geometry in an Amazonian indigene group. Science. 311, 381-384.
  15. Dehaene S, Changeux JP, Naccache L, Sackur J, Sergent C. (2006). Conscious, preconscious, and subliminal processing: a testable taxonomy. Trends Cogn Sci. 10, 204-211.
  16. Dehaene S, Naccache L. (2006). Can one suppress subliminal words? Neuron. 52, 397-399.
  17. Del Cul A, Dehaene S, Leboyer M. (2006). Preserved subliminal processing and impaired conscious access in schizophrenia. Arch Gen Psychiat. 63, 1313-1323.
  18. Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, Adams D, Samuel D, Merlet P, Syrota A, Slama MS, Le Guludec D. (2006). Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore). 85, 229-238.
  19. Dolle F, Emond P, Mavel S, Demphel S, Hinnen F, Mincheva Z, Saba W, Valette H, Chalon S, Halldin C, Helfenbein J, Legaillard J, Madelmont JC, Deloye JB, Bottlaender M, Guilloteau D. (2006). Synthesis, radiosynthesis and in vivo preliminary evaluation of [11C]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET. Bioorg Med Chem. 14, 1115-1125.
  20. Dollé F, Perrio C, Barré L, Lasne MC, Le Bars D. (2006). Les molécules marquées au fluor: Synthèse et application en imagerie médicale Actual Chimique. 93-98.
  21. Donnet S, Lavielle M, Poline JB. (2006). Are fMRI event-related response constant in time? A model selection answer. NeuroImage. 31, 1169-1176.
  22. Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi AC, Hantraye P, Remy P. (2006). Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI-based and voxel-based morphometric study. NeuroImage. 32, 1562-1575.
  23. Dubois J, Hertz-Pannier L, Dehaene-Lambertz G, Cointepas Y, Le Bihan D. (2006). Assessment of the early organization and maturation of infants' cerebral white matter fiber bundles: A feasibility study using quantitative diffusion tensor imaging and tractography. NeuroImage. 30, 1121-1132.
  24. Dubois J, Poupon C, Lethimonnier F, Le Bihan D. (2006). Optimized diffusion gradient orientation schemes for corrupted clinical DTI data sets. MAGMA. 19, 134-143.
  25. El Kouby V, Cointepas Y, Poupon C, Riviere D, Golestani N, Poline JB, Le Bihan D, Mangin JF. (2006). MR diffusion-based inference of a fiber bundle model from a population of subjects. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv.. 8, 196-204.
  26. Escartin C, Valette J, Lebon V, Bonvento G. (2006). Neuron-astrocyte interactions in the regulation of brain energy metabolism: a focus on NMR spectroscopy. J Neurochem. 99, 393-401.
  27. Gaillard R, Naccache L, Pinel P, Clemenceau S, Volle E, Hasboun D, Dupont S, Baulac M, Dehaene S, Adam C, Cohen L. (2006). Direct intracranial, FMRI, and lesion evidence for the causal role of left inferotemporal cortex in reading. Neuron. 50, 191-204.
  28. Gaillard R, Del Cul A, Naccache L, Vinckier F, Cohen L, Dehaene S. (2006). Nonconscious semantic processing of emotional words modulates conscious access. Proc Natl Acad Sci U S A. in print,
  29. Gaillard R, Del Cul A, Naccache L, Dehaene S. (2006). [Behavioural evidence of nonconscious semantic processing for emotional words.] Med Sci (Paris). 22, 702-704.
  30. Gervelas C, Serandour AL, Geiger S, Grillon G, Fritsch P, Taulelle C, Le Gall B, Benech H, Deverre JR, Fattal E, Tsapis N. (2006). Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: Effect on lung and systemic decorporation of plutonium J Control Release. AOP,
  31. Giurgea I, Sempoux C, Bellanne-Chantelot C, Ribeiro M, Hubert L, Boddaert N, Saudubray JM, Robert JJ, Brunelle F, Rahier J, Jaubert F, Nihoul-Fekete C, De Lonlay P. (2006). The Knudson's two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism. J Clin Endocrinol Metab. 91, 4118-4123.
  32. Giurgea I, Bellanne-Chantelot C, Ribeiro MJ, Hubert L, Sempoux C, Robert JJ, Blankenstein O, Hussain K, Brunelle F, Nihoul-Fekete C, Rahier J, Jaubert F, De Lonlay P. (2006). Molecular mechanisms of neonatal hyperinsulinism Horm Res. 66, 289-296.
  33. Golestani N, Alario FX, Meriaux S, Bihan DL, Dehaene S, Pallier C. (2006). Syntax production in bilinguals. Neuropsychologia. 44, 1029-1040.
  34. Golestani N, Molko N, Dehaene S, LeBihan D, Pallier C. (2006). Brain Structure Predicts the Learning of Foreign Speech Sounds. Cereb Cortex. in print,
  35. Grova C, Makni S, Flandin G, Ciuciu P, Gotman J, Poline JB. (2006). Anatomically informed interpolation of fMRI data on the cortical surface. NeuroImage. 31, 1475-1486.
  36. Herard AS, Besret L, Dubois A, Dauguet J, Delzescaux T, Hantraye P, Bonvento G, Moya KL. (2006). siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo. Neurobiol Aging. 27, 1740-1750.
  37. Jacquard C, Trioulier Y, Cosker F, Escartin C, Bizat N, Hantraye P, Cancela JM, Bonvento G, Brouillet E. (2006). Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation. FASEB J. 20, 1021-1023.
  38. Janssen KP, Vignjevic D, Boisgard R, Falguieres T, Bousquet G, Decaudin D, Dolle F, Louvard D, Tavitian B, Robine S, Johannes L. (2006). In vivo tumor targeting using a novel intestinal pathogen-based delivery approach. Cancer Res. 66, 7230-7236.
  39. Kleinschmidt A. (2006). Cognitive control signals in visual cortex: flashes meet spotlights. Neuron. 51, 09-11.
  40. Kleinschmidt A, Cohen L. (2006). The neural bases of prosopagnosia and pure alexia: recent insights from functional neuroimaging. Curr Opin Neurol. 19, 386-391.
  41. Kouider S, Dehaene S, Jobert A, Le Bihan D. (2006). Cerebral Bases of Subliminal and Supraliminal Priming during Reading. Cereb Cortex. in print,
  42. Kuhnast B, Valette H, Besret L, Demphel S, Coulon C, Ottaviani M, Guillermier M, Bottlaender M, Dolle F. (2006). Synthesis and radiolabeling of N-[4-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide -- a potential radiotracer for D3 receptor imaging with PET. Nucl Med Biol. 33, 785-795.
  43. Laffont-Proust I, Hassig R, Haik S, Simon S, Grassi J, Fonta C, Faucheux BA, Moya KL. (2006). Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts Biol Chem. 387, 297-300.
  44. Landmann C, Dehaene S, Pappata S, Jobert A, Bottlaender M, Roumenov D, Le Bihan D. (2006). Dynamics of Prefrontal and Cingulate Activity during a Reward-Based Logical Deduction Task. Cereb Cortex. In Print,
  45. De Lonlay P, Simon-Carre A, Ribeiro MJ, Boddaert N, Giurgea I, Laborde K, Bellanne-Chantelot C, Verkarre V, Polak M, Rahier J, Syrota A, Seidenwurm D, Nihoul-Fekete C, Robert JJ, Brunelle F, Jaubert F. (2006). Congenital Hyperinsulinism: pancreatic [18F]Fluoro-L-DOPA Positron Emission Tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab. 91, 933-940.
  46. Martins S, Guillery-Girard B, Jambaque I, Dulac O, Eustache F. (2006). How children suffering severe amnesic syndrome acquire new concepts? Neuropsychologia. 44, 2792-2805.
  47. Meriaux S, Roche A, Dehaene-Lambertz G, Thirion B, Poline JB. (2006). Combined permutation test and mixed-effect model for group average analysis in fMRI. Hum Brain Mapp. 27, 402-410.
  48. Mohnike K, Blankenstein O, Christesen HT, De Lonlay J, Hussain K, Koopmans KP, Minn H, Mohnike W, Mutair A, Otonkoski T, Rahier J, Ribeiro MJ, Schoenle E, Fekete CN. (2006). Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism Horm Res. 66, 40-42.
  49. Oppenheim C, Lamy C, Touze E, Calvet D, Hamon M, Mas JL, Meder JF. (2006). Do transient ischemic attacks with diffusion-weighted imaging abnormalities correspond to brain infarctions? Am J Neuroradiol. 27, 1782-1787.
  50. Pestourie C, Cerchia L, Gombert K, Aissouni Y, Boulay J, de Franciscis V, Libri D, Tavitian B, Duconge F. (2006). Comparison of different strategies to select aptamers against a transmembrane protein target. Oligonucleotides. 16, 323-335.
  51. Phan G, Le Gall B, Grillon G, Rouit E, Fouillit M, Benech H, Fattal E, Deverre JR. (2006). Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes. Biochimie. 88, 1843-1849.
  52. Phan G, Le Gall B, Deverre JR, Fattal E, Benech H. (2006). Predicting Plutonium Decorporation Efficacy after Intravenous Administration of DTPA Formulations: Study of Pharmacokinetic-Pharmacodynamic Relationships in Rats. Pharmaceut Res. 23, 2030-2035.
  53. Piazza M, Mechelli A, Price CJ, Butterworth B. (2006). Exact and approximate judgements of visual and auditory numerosity: An fMRI study. Brain Res. 1106, 177-188.
  54. Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schollhorn-Peyronneau MA, Roumenov D, Brodtkorb E, Zuberi S, Gambardella A, Steinborn B, Hufnagel A, Valette H, Bottlaender M (2006) Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain 129:2047-2060
  55. Plaze M, Bartres-Faz D, Martinot JL, Januel D, Bellivier F, De Beaurepaire R, Chanraud S, Andoh J, Lefaucheur JP, Artiges E, Pallier C, Paillere-Martinot ML. (2006). Left superior temporal gyrus activation during sentence perception negatively correlates with auditory hallucination severity in schizophrenia patients. Schizophr Res. 87, 109-115.
  56. Poline JB, Strother SC, Dehaene-Lambertz G, Egan GF, Lancaster JL. (2006). Motivation and synthesis of the FIAC experiment: Reproducibility of fMRI results across expert analyses. Hum Brain Mapp. 27, 351-359.
  57. Reader AJ, Sureau FC, Comtat C, Trebossen R, Buvat I. (2006). Joint estimation of dynamic PET images and temporal basis functions using fully 4D ML-EM. Phys Med Biol. 51, 5455-5474.
  58. Roger G, Saba W, Valette H, Hinnen F, Coulon C, Ottaviani M, Bottlaender M, Dolle F. (2006). Synthesis and radiosynthesis of [(18)F]FPhEP, a novel alpha(4)beta(2)-selective, epibatidine-based antagonist for PET imaging of nicotinic acetylcholine receptors. Bioorg Chem. 14, 3848-3848.
  59. Roger G, Hinnen F, Valette H, Saba W, Bottlaender M, Dolle F. (2006). Radiosynthesis of 2-exo-(2 '-[F-18]fluoro-3 '-(4-fluorophenyl)-pyridin-5 '-yl)-7-azabicyclo[2.2.1]heptane ([F-18]F2PhEP), a potent epibatidine-based radioligand for nocotinic acetylcholine receptor PET imaging J Labelled Compd Rad. 49, 489-504.
  60. Sedel F, Ribeiro MJ, Remy P, Blau N, Saudubray JM, Agid Y. (2006). Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia. Neurology. 67, 2243-2245.
  61. Sigman M, Dehaene S. (2006). Dynamics of the Central Bottleneck: Dual-Task and Task Uncertainty. PLoS Biol. 4, 220.
  62. Stankoff B, Wang Y, Bottlaender M, Aigrot MS, Dolle F, Wu C, Feinstein D, Huang GF, Semah F, Mathis CA, Klunk W, Gould RM, Lubetzki C, Zalc B. (2006). Imaging of CNS myelin by positron-emission tomography. Proc Natl Acad Sci U S A. 103, 9304-9309.
  63. Thirion B, Dodel S, Poline JB. (2006). Detection of signal synchronizations in resting-state fMRI datasets NeuroImage. 29, 321-327.
  64. Thirion B, Flandin G, Pinel P, Roche A, Ciuciu P, Poline JB. (2006). Dealing with the shortcomings of spatial normalization: Multi-subject parcellation of fMRI datasets. Hum Brain Mapp. 27, 678-693.
  65. Thirion B, Pinel P, Poline JB. (2006). Finding landmarks in the functional brain: detection and use for group characterization. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv.. 8, 476-483.
  66. Thirion B, Duchesnay E, Hubbard E, Dubois J, Poline J-B, LeBihan D, Dehaene S. (2006). Inverse retinotopy: Inferring the visual content of images from brain activation patterns NeuroImage. 33, 1104-1116.
  67. Thominiaux C, de Bruin B, Bramoullé Y, Hinnen F, Demphel S, Valette H, Bottlaender M, Besret L, Kassiou M, Dollé F. (2006). Radiosynthesis of (E)-N-(2-[11C]methoxybenzyl)-3-phenyl-acrylamidine, a novel subnanomolar NR2B subtype-selective NMDA receptor antagonist Appl Radiat Isot. 64, 348-354.
  68. Thominiaux C, Dolle F, James ML, Bramoulle Y, Boutin H, Besret L, Gregoire MC, Valette H, Bottlaender M, Tavitian B, Hantraye P, Selleri S, Kassiou M. (2006). Improved synthesis of the peripheral benzodiazepine receptor ligand [(11)C]DPA-713 using [(11)C]methyl triflate. Appl Radiat Isot. 64, 570-573.
  69. Thominiaux C, de Bruin B, Bramoulle Y, Hinnen FO, Demphel S, Valette H, Bottlaender M, Besret L, Kassiou M, Dolle F. (2006). Radiosynthesis of (E)-N-(2-[C-11]methoxybenzyl)-3-phenyl-acrylamidine, a novel subnanomolar NR2B subtype-selective NMDA receptor antagonist Appl Radiat Isot. 64, 348-354.
  70. Valette J, Guillermier M, Boumezbeur F, Poupon C, Amadon A, Hantraye P, Lebon V. (2006). B(0) homogeneity throughout the monkey brain is strongly improved in the sphinx position as compared to the supine position. J Magn Reson Imag. 23, 408-412.
  71. Valette J, Guillermier M, Besret L, Hantraye P, Bloch G, Lebon V. (2006). Isoflurane strongly affects the diffusion of intracellular metabolites, as shown by (1)H nuclear magnetic resonance spectroscopy of the monkey brain. J Cereb Blood Flow Metab. In Print,
  72. Vercouillie J, Mavel S, Galineau L, Ragusa T, Innis R, Kassiou M, Chalon S, Dolle F, Besnard JC, Guilloteau D, Emond P. (2006). Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands. Bioorg Med Chem Lett. 16, 1297-1300.
  73. Vinckier F, Naccache L, Papeix C, Forget J, Hahn-Barma V, Dehaene S, Cohen L. (2006). "What" and "where" in word reading: ventral coding of written words revealed by parietal atrophy. J Cogn Neurosci. 18, 1998-2012.
  74. Wilson AJ, Dehaene S, Pinel P, Revkin SK, Cohen L, Cohen D. (2006). Principles underlying the design of "The Number Race", an adaptive computer game for remediation of dyscalculia. Behav Brain Sci. 2, 19.
  75. Zala D, Benchoua A, Brouillet E, Perrin V, Gaillard MC, Zurn AD, Aebischer P, Deglon N. (2006). Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiol Dis. 20, 785-798.
  76. Zhang C. (2006). Interaction between tyrosine(Z) and substrate water in active photosystem II. Biochim Biophys Acta Bioenergetics. 1757, 781-786.
  77. Zilbovicius M, Meresse I, Boddaert N. (2006). [Autism: neuroimaging] Rev Bras Psiquiatr. 28, S21-S28.
  78. Zilbovicius M, Meresse I, Chabane N, Brunelle F, Samson Y, Boddaert N. (2006). Autism, the superior temporal sulcus and social perception. Trends Neurosci. 29, 359-366.
2012 - 2011 - 2010 - 2009 - 2008 - 2006 - 2005 - 2004 - 2003 - 2002